Sequoia Financial Group Limited Overview
Sequoia Financial Group is a micro-cap Australian financial-services company that, until October 2026, was best known as the owner of InterPrac Financial Planning, one of the country's larger non-aligned advice licensees. The group's model rested on two divisions. The first, Licensee & Adviser Services, sold licensing, compliance, platform access and salaried advice. The second, Legal & Administration Services, sells legal documents, company structures, SMSF administration and AML tooling to accountants and lawyers. Smaller media, corporate-finance and minority investment holdings sit alongside them. The collapse of the Shield and First Guardian master funds changed the company's position fundamentally. InterPrac-authorised advisers placed client superannuation into those funds, which triggered ASIC civil-penalty proceedings, more than 900 AFCA complaints, a 10-year banning of the former CEO, a going-concern qualification and the forced exit of InterPrac. What remains is a small, capital-light document and services business, a residual wealth franchise and a listed-equity portfolio. Large contingent-liability questions still overhang all of it.
Company's own description
Sequoia's standard ASX boilerplate (repeated in 2026 announcements) describes it as serving the retail and wholesale clients of financial planners, brokers, accounting firms and legal practitioners. It lists six activities:
-
financial services licensing through three separate AFSLs
-
salaried advice
-
corporate advisory and capital-markets expertise
-
establishment of legal structures and documents
-
media
-
SMSF administration
The FY2025 Annual Report presents the group as streamlined around two scalable divisions:
Licensee & Adviser Services (LAS): Serves both the retail and wholesale advice markets through the InterPrac and Sequoia Wealth Management brands.
Legal & Administration Services (L&AS): FY2025 strategic priorities were to expand adviser numbers at InterPrac, grow Sequoia Wealth Management, grow salaried advice, build a profitable media business and drive operating efficiency.
Independent characterisation
Sequoia was a B2B2C services aggregator sitting between product manufacturers (platforms, super funds, fund managers, insurers) and end investors. Most of its revenue was pass-through.
InterPrac's economics: InterPrac collected advice fees and commissions on behalf of authorised representatives (ARs) and retained a licensee margin. This explains why group revenue exceeded A$100m while operating profit (normalised EBITDA) was only A$4–12m a year. LAS generated A$113.2m of A$124.1m group revenue in FY2025, and the bulk of that was gross adviser revenue.
Legal & Administration Services: This was the genuinely higher-margin, capital-light franchise, built around Docscentre-style document automation, company structures (Castle Corporate, Australian Business Structures), SMSF administration and, from 1 July 2026, an AML platform.
Other assets: These include media (Finance News Network / ShareCafe), corporate finance, and minority stakes in Morrison Securities (20%), Euree Asset Management (20%) and a listed holding in Centrepoint Alliance (about 15% before a September 2026 sell-down).
Revenue model mix
| Revenue type | Description | Indicative weight |
|---|---|---|
| Advice / licensee fees and commissions (pass-through) | AR advice fees, ongoing fees and insurance commissions collected under InterPrac / Sequoia Wealth AFSLs | Dominant: LAS was 91% of FY2025 revenue and 90% of FY2026 revenue (company segment data) |
| Salaried advice fees | Direct advice from employed advisers | Included in LAS; not separately disclosed |
| Transactional / subscription services | Legal documents, company and trust establishment, SMSF administration, AML compliance | L&AS: A$9.7m in FY2025, A$10.3m in FY2026 |
| Corporate finance fees | Capital-raising and advisory fees | Included in LAS; weaker trading noted in 1H FY2025 |
| Media / advertising | Investor-relations video and news (FNN / ShareCafe) | — |
| Investment income | Equity-accounted and listed-equity returns | Non-operating; drove FY2025 EBITDA uplift |
Customers and end markets
-
Financial planners and practices (authorised representatives)
-
Accountants and SMSF practitioners
-
Small legal practices and tax agents
-
Retail and wholesale investors (the advice clients)
-
ASX-listed small caps (media and corporate finance)
All revenue is generated in Australia.
Strategy
Stated strategy (paraphrased from company disclosures)
FY2025 Annual Report:
-
Simplify into two scalable divisions.
-
Expand InterPrac and Sequoia Wealth Management adviser numbers.
-
Grow salaried advice and media.
-
Invest in compliance monitoring, data analytics and adviser platforms.
-
Strengthen governance through the independent AFSL Governance Committee.
1H FY2026 (Feb 2026):
-
Progressively rebalance earnings away from reliance on InterPrac toward higher-control, higher-margin activities: salaried advice, corporate finance and L&AS.
-
Run a comprehensive review of the InterPrac model.
FY2026 outlook (Aug 2026):
-
Make finding a path to resolving the InterPrac legal matters the FY2027 priority.
-
Selectively pursue opportunities in other divisions.
-
Once legal matters are resolved, use the diversified businesses to build a broader earnings base.
Initiatives in the last 24 months
| Initiative | Date | Detail / target |
|---|---|---|
| Two-division restructure | FY2025 | About A$1.5m p.a. employment-cost savings |
| Five non-core exits | Jul–Oct 2024 | Insurance broking ×2, Informed Investor, Corporate Connect Research, plus closures |
| AFSL Governance Committee | FY2025 | Chaired by Danielle Press |
| AI compliance tooling; adviser removals | FY2025 | Response to breaches |
| Licensee Services growth targets | FY2025 presentation | More advisers, higher revenue per adviser and higher EBITDA. Now superseded. |
| InterPrac comprehensive review → divestment | Feb–Oct 2026 | Completed 13 Oct 2026 (Bellbird, A$200,000) |
| AML platform | Live 1 Jul 2026 | Positions L&AS for AML/CTF reform affecting accountants and lawyers |
| Cash-raising / asset realisation | Sep 2026 | Sell-down of Centrepoint stake; going-concern plan cites realising liquid assets |
| Capital management | Ongoing | Buyback ends 18 Sep 2026; dividends suspended until circumstances allow |
Medium-term targets
-
Earlier aspirations (FY2023) included a A$300m revenue target within five years and a 15% operating-profit return on equity for every division. These are clearly superseded.
-
No current quantitative guidance has been published for FY2027.
-
ESG targets have not been disclosed.
Products & Services
Licensee & Adviser Services
| Offering | Description | Target customer | Status (Oct 2026) |
|---|---|---|---|
| InterPrac Financial Planning (AFSL) | Non-aligned licensee giving ARs compliance, PI, approved product list, education and platform access; historically close to the NTAA accounting body | Self-employed planners and accountant-advisers | Divested 13 Oct 2026 to Bellbird Australia for A$200,000 |
| Sequoia Wealth Management (AFSL) | Licensee proposition aimed at wholesale / higher-net-worth advice | Wholesale-oriented advisers | Retained; adviser numbers not disclosed |
| Sequoia Asset Management (AFSL) | Third AFSL in the group; investment / product licensing | Advisers and investors | Retained; detail not disclosed |
| Salaried advice | Employed advisers, including InterPrac's salaried team that worked with affected Shield / First Guardian clients | Retail clients | Status post-sale not disclosed |
| Clique Paraplanning | Paraplanning services acquired FY2024 | Advice practices | Retained (assumed; not confirmed) |
| Corporate finance / capital markets | Capital raising and corporate advisory for small caps | ASX micro / small caps | Retained; weaker trading in 1H FY2025 |
| Media: Finance News Network, ShareCafe | Investor-relations video, interviews and financial news; rebranding flagged after earlier court proceedings | Listed companies, retail investors | Retained |
| Libertas Financial Planning | Former licensee (acquired 2019) | — | Liquidated 2023; AFSL cancelled 14 Aug 2024 |
| General insurance broking (Sequoia Insurance Brokers, InterPrac General Insurance) | General insurance broking | SMEs / clients | Sold 1 Jul 2024 to WIB Corporate |
| Two further insurance-broking subsidiaries | Underperforming broking businesses | — | Sold in 1H FY2026 at a A$2.1m loss |
| Informed Investor | Investor media / content | Retail investors | Sold 20 Sep 2024 (Powerhouse Ventures) |
| Corporate Connect Research | Sponsored equity research | Listed small caps | Sold 31 Oct 2024 |
| Shield / First Guardian (on approved product list) | Third-party master-fund options placed by certain ARs | — | New business ceased (FY2025); at centre of litigation |
Legal & Administration Services
| Offering | Description | Target customer | Status |
|---|---|---|---|
| Docscentre (legal documents) | Online legal-document automation: trusts, SMSF deeds, wills / estate documents, company constitutions | Accountants, planners, lawyers | Core growth engine; management cites rising market share |
| Company and trust establishment | Incorporation and structure registration | Accountants / tax agents | Retained |
| Castle Corporate / Castle Legal | Business assets acquired Aug 2023, adding share in documents and corporate services | Accountants / lawyers | Integrated |
| Australian Business Structures (ABS) | Customer book acquired FY2024–FY2025 | Accountants | Integrated |
| SMSF administration | Fund administration and compliance | SMSF trustees via accountants | Retained |
| AML platform | New anti-money-laundering compliance platform, live 1 July 2026, timed for AML/CTF "tranche 2" obligations on accountants and lawyers | Accountants, lawyers, real estate | Launched FY2027 |
| AI compliance tools | AI-enabled compliance monitoring deployed within L&AS (FY2025) | Internal / clients | Implemented |
Investments (non-consolidated)
| Holding | Stake | Nature |
|---|---|---|
| Morrison Securities | 20.0% (30 Jun 2026) | Clearing / settlement; 80% sold to New Quantum for A$40.5m (2023) |
| Euree Asset Management | 20.0% (30 Jun 2026) | Multi-asset fund manager supplying options to advisers |
| Centrepoint Alliance (ASX: CAF) | About 15% (May 2026), then sold down (Sep 2026) | Listed licensee competitor; part of the A$14.4m listed equities at 30 Jun 2026 |
Pricing models were not disclosed for any product line.
Financial Narrative
Important comparability note: FY2022 and FY2023 include Morrison Securities (an equities clearer with high pass-through revenue) and the subsequently divested insurance-broking businesses. FY2024 onward is closer to like-for-like. FY2024 NPAT includes a A$27.1m divestment contribution.
Income statement
Sources and notes:
-
FY2022 revenue is derived from FY2023 revenue of A$131.5m being down 10.7%. FY2022 EBITDA of A$12.4m is from the FY2023 AGM address.
-
FY2023 NPAT is derived from FY2024 NPAT growth of 1,012%.
-
FY2024 data is from the company release of 27 Aug 2024.
-
FY2025 data is from the Appendix 4E. The FY2026 release restates FY2025 operating profit as A$9.8m and NPBT as A$5.8m.
-
FY2026 data is from the 28 Aug 2026 release. The audited NPAT is –A$8,576,002.
-
Gross profit and EBIT are not publicly disclosed in the sources reviewed.
Dividend detail
The FY2026 interim of 1.0c was determined on 23 Feb 2026. It was deferred three times and revoked on 13 Aug 2026, so it was never paid. The FY2023 special was declared in September 2023 after Morrison completion; it is attributed to FY2023 here, consistent with the company's statement that FY2024's 7.0c was up 49%.
Margins and growth
-
Revenue CAGR FY2022–FY2026 is –8.0% (derived). Revenue CAGR FY2024–FY2026 is also –8.0% (derived).
-
Gross margin is not meaningful or disclosed, given the pass-through adviser revenue.
Balance sheet
The following were not publicly disclosed in the sources reviewed:
-
Total assets, equity, goodwill and intangibles, and working capital for all years. Goodwill would be material given the InterPrac, Libertas, Castle and ABS acquisitions, and FY2026 included impairment costs.
-
Total debt for FY2025 and FY2026.
The group described itself as debt-free in FY2024. It held a A$15m ANZ acquisition facility in 2023.
FY2025 cash is described as net cash of A$4.4m. FY2026 cash is reported as A$1.6m without net-debt disclosure.
Cash flow
-
FY2023 operating cash flow is derived from FY2024 OCF being up 69%.
-
Capex, free cash flow and dividends paid were not publicly disclosed in the sources reviewed.
-
Buybacks reduced issued capital by 4.3% in FY2024 and continued through FY2025–FY2026. The buyback formally ends on 18 Sep 2026, and a share-cessation notice was lodged on 9 Mar 2026.
Commentary on trends, inflections and drivers
FY2022 → FY2023 (inflection down).
-
Revenue fell 10.7% and operating profit 55.6% as equity-market volumes contracted.
-
Equity Markets revenue dropped 40% to A$41.7m.
-
Non-recurring PI settlements from 2019-era advice (about A$1.6m) hit Licensee Services.
-
Management responded by monetising Morrison (A$40.5m for 80%), the single most value-accretive transaction of the period.
FY2024 (cosmetic peak).
-
Statutory NPAT of A$24.0m was almost entirely the A$27.1m Morrison divestment contribution.
-
Continuing revenue grew 26% to A$124.6m and operating profit 88% to A$8.7m, helped by adviser recruitment.
-
The second half was disrupted by the board-control contest. Management cited employee and adviser unrest and extra retention costs.
FY2025 (simplification).
-
Five non-core exits cut complexity while revenue held at A$124.1m.
-
EBITDA rose 13.7% to A$9.9m, helped by margin discipline and investment-portfolio gains.
-
Cash fell from A$16.8m to A$4.4m net. The decline reflects dividends (7.0c in FY2024 plus 4.0c in FY2025), buybacks and investments; the precise bridge was not disclosed.
FY2026 (structural break).
-
The Shield / First Guardian fallout drove InterPrac ARs down 63% (294 → 110) and LAS revenue down A$18m.
-
Operating profit more than halved to A$4.4m. The first half had actually improved (+75.9% to A$4.8m), which implies a negative second-half operating result of about –A$0.4m (derived).
-
Statutory loss of A$8.6m came from losses on sale of subsidiaries, impairments and higher legal costs. 1H items included a A$0.9m Libertas settlement and a A$2.1m loss on sale of two broking subsidiaries.
-
Cash fell to A$1.6m. Liquidity now rests heavily on the A$14.4m listed-equity book, part of which (Centrepoint) was sold in September 2026 as a cash-raising measure.
Unlock Company Financials
Unlock this company profile to view its financial data.
View Subscription PlansFinancial Detail
Reporting Divisions by Period
| Period | Reporting divisions |
|---|---|
FY2023 | Four divisions: Licensee Services, Equity Markets (incl. Morrison), Professional Services, Direct (media / investments) |
FY2024 (transition) | Four divisions, with Morrison deconsolidated |
1H FY2025 onward | Two divisions: Licensee & Adviser Services; Legal & Administration Services (plus corporate / investments) |
Post-13 Oct 2026 | LAS loses InterPrac. Remaining LAS assets are Sequoia Wealth Management, salaried advice, corporate finance and possibly media. The new segment definitions are not yet published. |
Revenue by Segment
| Segment | FY2024 | FY2025 | FY2026 |
|---|---|---|---|
Licensee & Adviser Services revenue (AUD Mn) | — | 113.2 | 95.2 |
Legal & Administration Services revenue (AUD Mn) | — | 9.7 | 10.3 |
Group revenue (AUD Mn) | 124.6 | 124.1 | 105.4 |
Unlock Company Financials
Unlock this company profile to view its financial data.
View Subscription PlansSegment Margins & Growth (%) and Revenue by Segment (%)
| Segment metric | FY2025 | FY2026 |
|---|---|---|
LAS YoY growth (%) | — | -15.9 |
L&AS YoY growth (%) | — | 6.2 |
LAS share of group revenue (%) | 91.2 | 90.3 |
L&AS share of group revenue (%) | 7.8 | 9.8 |
Revenue by Segment (Half-Yearly)
| Segment | 1H FY2024 | 1H FY2025 |
|---|---|---|
LAS revenue (AUD Mn) | 57.9 | 55.8 |
Division (FY2023) Overview
| Division (FY2023) | Revenue AUD Mn | Operating profit AUD Mn | Comment |
|---|---|---|---|
Licensee Services | — | 3.8 | About 6.0 before about A$1.6m non-recurring PI settlements from 2019 advice |
Equity Markets | 41.7 | — | Revenue down 40%; operating profit down about A$4m |
Professional Services | 8.5 | 2.4 | Revenue up 9.0% |
Revenue by Segment — Funds under advice
| KPI | FY2024 | FY2025 | FY2026 |
|---|---|---|---|
Funds under advice (AUD Bn) | 12.5 | 18.0 | — |
Advisers (InterPrac ARs, start → end of year) | — | 294 | 110 |
Licensee network advisers (all AFSLs, FY2025 presentation) | — | 321 | — |
Practices (FY2025 presentation) | — | 219 | — |
Income Statement and Per-Share Data
| Metric | FY2022 | FY2023 | FY2024 | FY2025 | FY2026 |
|---|---|---|---|---|---|
Revenue (AUD Mn) | 147.3 | 131.5 | 124.6 | 124.1 | 105.4 |
Operating profit / normalised EBITDA (AUD Mn) | 12.4 | 5.5 | 8.7 | 9.9 | 4.4 |
Net profit before tax (AUD Mn) | — | — | — | 5.9 | -8.7 |
Net profit after tax (AUD Mn) | — | 2.2 | 24.0 | 3.2 | -8.6 |
EPS basic (A$ cents) | — | — | — | 2.59 | -6.97 |
Dividends per share, total (A$ cents) | 1.4 | 4.7 | 7.0 | 4.0 | 0 |
Dividend (A$ cents, fully franked)
| Dividend (A$ cents, fully franked) | FY2022 | FY2023 | FY2024 | FY2025 | FY2026 |
|---|---|---|---|---|---|
Interim | 0.5 | 0.7 | 2.0 | 2.0 | 0 |
Final | 0.9 | 0 | 2.5 | 2.0 | 0 |
Special | 0 | 4.0 | 2.5 | 0 | 0 |
Margin Analysis (%)
| Ratio | FY2022 | FY2023 | FY2024 | FY2025 | FY2026 |
|---|---|---|---|---|---|
Operating (EBITDA) margin (%) | 8.4 | 4.2 | 7.0 | 8.0 | 4.2 |
Net margin (%) | — | 1.7 | 19.3 | 2.6 | -8.2 |
Revenue growth YoY (%) | — | -10.7 | -5.2 | -0.4 | -15.1 |
Balance Sheet
| Metric | FY2024 | FY2025 | FY2026 |
|---|---|---|---|
Cash / net cash (AUD Mn) | 16.8 | 4.4 | 1.6 |
Listed equity investments (AUD Mn) | — | 16.0 | 14.4 |
Cash Flow
| Metric | FY2023 | FY2024 |
|---|---|---|
Operating cash flow (AUD Mn) | 2.8 | 4.8 |
Financial Analysis
| Ratio | Assessment |
|---|---|
ROE / ROA / ROIC | Not calculable from verified data. FY2026 is negative given the A$8.6m loss. |
Current ratio, D/E, interest coverage | Not publicly disclosed in sources reviewed. Historically low leverage; FY2026 debt not disclosed. |
Net debt / EBITDA | FY2025: net cash, so the ratio is negative. FY2026: not determinable. |
Asset turnover, cash conversion cycle | Not meaningful for a licensee / services model; not disclosed. |
Revenue by Region and Revenue by Region (%)
| Region | FY2024 | FY2025 | FY2026 |
|---|---|---|---|
Australia revenue (AUD Mn) | 124.6 | 124.1 | 105.4 |
Australia share of revenue (%) | 100 | 100 | 100 |
Operating Areas
| Area | Direction | Reason |
|---|---|---|
Legal & Administration Services | Growing (+6.2% in FY2026) | Docscentre share gains, Castle / ABS acquisitions, AML platform investment |
Salaried advice / corporate finance | Management says margins are improving (1H FY2026) | Higher-control model; revenue not separately disclosed |
InterPrac licensee revenue | Collapsing (–15.9% LAS; ARs –63%) | Shield / First Guardian, HUB24 cessation of new business, adviser departures, ASIC litigation |
Insurance broking, research, Informed Investor | Exited | Non-core divestments in FY2025–FY2026 |
Share Price & Returns
| Reference date | Share price (AUD) | Source |
|---|---|---|
Sep 2023 (approx.) | Market cap about A$70m | FNN interview |
Aug 2025 | Market cap about A$37m | TipRanks |
23 Feb 2026 | 0.260 | InvestSMART release price |
20 Mar 2026 | 0.230 | InvestSMART |
1 May 2026 | 0.205 | InvestSMART |
22 Jul 2026 | 0.110 | InvestSMART |
13 Aug 2026 | 0.115 → 0.085 | InvestSMART |
Mid-Oct 2026 | 0.065 (market cap about A$7.97m) | Listcorp |
Valuation Snapshot
| Multiple | Value | Comment |
|---|---|---|
Market cap (AUD Mn) | About 8.0 | Price × about 122.6m shares |
EV/EBITDA | Negative | Cash A$1.6m plus listed equities A$14.4m (30 Jun 2026) exceed market cap, before contingent liabilities and post-balance-date changes |
P/B | Not calculable | — |
Analyst Conclusions
Management guidance
-
No quantitative FY2027 guidance has been published.
-
The stated priority is to find a path to resolving the InterPrac-related legal matters while selectively pursuing opportunities in other divisions (FY2026 release).
Consensus
None available.
Bull case
-
Clean exit. If the Bellbird sale and cross-guarantee revocation withstand ASIC scrutiny, the group is ring-fenced from the A$677m-scale Shield / First Guardian exposure. The remaining businesses (L&AS at A$10.3m revenue and growing, plus Sequoia Wealth, media and corporate finance) then sit on about A$16m of cash and listed equities, against a market cap of about A$8m.
-
AML-led growth. The AML platform (live 1 Jul 2026) and Docscentre share gains could turn L&AS into a recurring, high-margin regtech business that warrants a software-style multiple.
-
Activist catalyst. AWAG's about 18% stake and its consolidation intentions, together with a fragmented register, create potential for a control transaction once legal noise subsides.
Bear case
-
Regulatory look-through. ASIC has already litigated once to protect InterPrac creditors and is closely scrutinising the Bellbird deal. A challenge, a claw-back or claims tied to directors' conduct could put liabilities back on the group, which is already carrying a going-concern qualification.
-
Cash runway. With A$1.6m cash at 30 June 2026, an FY2026 second-half operating result near breakeven or negative, and continuing legal costs, the listed-equity book may be consumed before the residual businesses scale.
-
Franchise impairment. The scandal, the former CEO's ban and the Libertas precedent may damage Sequoia Wealth Management, media and L&AS relationships with accountants and platforms. That would erode the "diversified operations" management now relies on.
Catalysts and monitorables (next 12 months)
| Catalyst | Timing | Why it matters |
|---|---|---|
| ASIC response to the Bellbird sale / cross-guarantee revocation | Q4 CY2026 – 1H CY2027 | Determines whether the liability ring-fence holds |
| FY2026 Annual Report / AGM (incl. remuneration votes, director elections) | About Nov 2026 | Board renewal; permanent chair and CEO appointments |
| 1H FY2027 results (pro-forma ex-InterPrac) | About Feb 2027 | First view of the residual group's earnings and cash burn |
| InterPrac v AFCA judgment | Unknown | Sets loss-allocation precedent |
| ASIC v InterPrac case management | 9 Apr 2027 | Any findings implicating former group officers |
| Crole Administrative Review Tribunal review (if sought) | Unknown | Reputational read-through |
| AML/CTF tranche-2 commencement and platform uptake | CY2026–2027 | L&AS growth |
| Further asset realisations (Centrepoint, Morrison, Euree) | Ongoing | Liquidity and possible capital return |
Concluding analyst verdict
Sequoia Financial Group in October 2026 is a fundamentally different company from the one that reported a 13.7% EBITDA increase and 4.0 cents of franked dividends only fourteen months earlier.
The collapse of the Shield and First Guardian master funds exposed serious alleged oversight failures at InterPrac, the group's dominant revenue engine. It set off a chain of consequences:
-
ASIC civil-penalty proceedings
-
more than 900 AFCA complaints
-
withdrawal of platform support
-
a 63% fall in authorised representatives
-
a statutory loss of A$8.6 million
-
an auditor's going-concern warning
-
the 10-year banning of the founder-CEO
-
the sale of InterPrac for A$200,000, against an A$12.83 million purchase price in 2017
On a narrow balance-sheet view, the stock looks optically cheap. At about A$8 million of market capitalisation, it trades below the A$14.4 million of listed equities and A$1.6 million of cash held at 30 June 2026. The retained Legal & Administration Services business is growing and now has a timely AML product.
That arithmetic is misleading without a liability overlay. The central uncertainty is whether the Bellbird transaction and the revocation of the cross guarantee will survive regulatory and judicial scrutiny. ASIC has shown it is willing to litigate on exactly this point, and it has said publicly that it is examining the deal closely. Legal costs, possible penalties and residual compensation exposure, together with an interim leadership team and a damaged brand, make the equity a binary, event-driven instrument rather than an investment in an operating franchise.
Verdict: Speculative / Avoid for fundamental investors. The stock is suitable only for special-situations capital that can underwrite legal outcomes. A credible re-rating would require three things: ASIC acceptance of the InterPrac exit, appointment of a permanent and credentialed board and CEO, and evidence from the 1H FY2027 accounts that the residual group can operate at or above cash breakeven without consuming its investment portfolio.
All figures are in A$ for fiscal years ending 30 June unless stated. "Derived" figures are arithmetic from disclosed data.
Unlock Company Financials
Unlock this company profile to view its financial data.
View Subscription PlansExecutive Leadership
Board of Directors
| Name | Role | Appointed | Background / notes |
|---|---|---|---|
Alex Fabbri | Interim CEO | 22 Jul 2026 | Background not disclosed in sources reviewed. Delivered the FY2026 results commentary. |
David Hentschke | Interim Chair; Non-Executive Director | Interim chair 22 Jul 2026 | — |
Floriane Allard | Director (remunerated role) | 22 Jul 2026 | Annual salary A$211,300 plus super and discretionary bonus, which indicates an executive role |
Daryl Stout | Head of Licensee Services | FY2025 | Appointed to strengthen licensee governance |
Danielle Press | Chair, independent AFSL Governance Committee | FY2025 | Former ASIC Commissioner. Board status not confirmed. |
Natalie Climo | Company Secretary | — | Boardroom Pty Ltd |
Executive Leadership Team
| Name | Former role | Dates | Notes |
|---|---|---|---|
Garry Crole | Group CEO and MD; director | Director 18 Nov 2016 – 22 Jul 2026 | Resigned 21/22 Jul 2026. Banned by ASIC for 10 years from 4 Sep 2026; ASIC found he was not fit and proper. Remains a substantial shareholder (7.3% per FY2024 AR). Can seek review at the Administrative Review Tribunal. |
Michael (Mike) Ryan | Chair | Resigned mid-2026 | Date discrepancy: Professional Planner reports 27 May 2026; Financial Standard reports 16 Jun 2026 |
Charles Sweeney | Chair (newly appointed in 2024) | — | Chair during the 2024 control contest |
Kevin Pattison | Non-Executive Director | 2024 status | — |
John Larsen | Non-Executive Director (formerly co-signed results as chair) | About 2019 – May 2024 | Stepped down in May 2024 |
Lizzie Tan | CFO and COO | FY2024 | — |
Scott Beeton | MD / CEO | About 2017 | Led the InterPrac acquisition |
Brent Jones | Head of Professional Services; former InterPrac director | — | Nominated by requisitioning shareholders in 2024 |
Major Shareholders
| Holder | Stake | Date / source |
|---|---|---|
The Australian Wealth Advisors Group (AWAG) | About 18.0–18.2% (22.37m shares) | 30 Jan 2025 substantial-holder notice |
Unrandom Pty Ltd (Brent Jones-linked) | 7.8% (about 10m shares) | FY2024 Annual Report top 20 |
Garry Crole (and associates) | 7.3% (about 9.2m shares) | FY2024 Annual Report. Confirmed as still a substantial shareholder in Jul 2026; director's interest notices lodged 22 and 24 Jul 2026. |
A. Jones Group / Glennon Capital | Combined voting power with Unrandom rose from about 22.2% to 27.84% in 2024 | Subject to Takeovers Panel orders, Jul 2024 |
Competitive Landscape
Competitors by Segment
| Segment | Competitor | Positioning vs Sequoia |
|---|---|---|
Licensee services | Centrepoint Alliance (ASX: CAF) | 500+ ARs plus about 200 self-licensed practices (2025); 1H FY2026 net revenue A$21.5m (+7%). Now a consolidator. |
Licensee services | Count Ltd (ASX: CUP) | — |
Licensee services | WT Financial Group (ASX: WTL) | Listed licensee in multi-year growth / transformation |
Licensee services | The Australian Wealth Advisors Group (ASX: WAG) | Equity-partnership model; about 18% holder of SEQ and 17.1% voting power in CAF |
Licensee services | Insignia Financial (advice), AMP (advice) | Institutional-legacy networks |
Licensee services | Infocus, Fitzpatricks, Lifespan (private) | Mid-tier non-aligned licensees |
Legal documents | NowInfinity (HUB24 / Class), Cleardocs (Thomson Reuters), Legal Consolidated | Direct competitors to Docscentre in trust, SMSF and company documents |
SMSF administration | Class, SuperConcepts, Heffron | Larger-scale administrators |
Financial media | Market Index, Livewire, Stockhead, Proactive | Compete with FNN / ShareCafe for small-cap IR budgets |
Peer Comparison FY2026
| Metric | Sequoia (FY2026) | Centrepoint Alliance |
|---|---|---|
Revenue (AUD Mn) | 105.4 (gross) | 21.5 (net revenue, 1H FY2026 only) |
Growth (%) | -15.1 | 7 (1H FY2026) |
Operating margin (%) | 4.2 | — |



